LongevitySignal
Subscribe

What changed in longevity
this week

Research, supplements, protocols, and longevity breakthroughs — without the noise.

Advancements in Cancer Science: Prevention, Detection, and Treatment Insights from Siddhartha Mukherjee
Research3h ago

Advancements in Cancer Science: Prevention, Detection, and Treatment Insights from Siddhartha Mukherjee

In a recent discussion, Dr. Siddhartha Mukherjee highlighted the evolving understanding of cancer, emphasizing the metabolic differences between cancerous and normal cells. He pointed out that advancements in second and third-line therapies for specific cancers could significantly extend patient lifespans. This evolving science underscores the importance of early detection and innovative treatment approaches in the fight against cancer.

Age-Related Decline in Chapero
Research21h ago

Age-Related Decline in Chapero

The latest Fight Aging! newsletter discusses the age-related decline observed in the Chapero, a biological mechanism linked to aging. This decline is significant as it highlights the need for further research into the mechanisms of aging and their implications for age-related diseases. Understanding these mechanisms can lead to potential interventions that may improve longevity and healthspan.

Exploring the Connection Between Big Pharma and Gray-Market Peptides
Biotechyesterday

Exploring the Connection Between Big Pharma and Gray-Market Peptides

A recent analysis reveals significant ties between the pharmaceutical industry and gray-market peptides, highlighting a complex relationship that goes beyond public perception. The study traced the patent and development histories of 25 popular compounds, uncovering deeper connections to big pharma than previously understood. This relationship raises important questions about the safety and efficacy of these peptides for health optimization.

Latest

Research2d ago

Exploring the Link Between Socioeconomic Status and Life Expectancy

A recent analysis investigates the correlation between socioeconomic status (SES) and life expectancy, focusing on the role of lifestyle choices. While SES is known to influence longevity through factors like wealth and education, establishing direct causation remains complex. The study employs mediation analysis to better understand these relationships, although definitive proof is still elusive.

Research2d ago

Blocking STING Helps Preserve Bone in Aging Mice

A recent study has identified a link between STING-mediated signals from marrow fat cells and inflammation, which contributes to the decline of NAD⁺ levels in bone-forming cells. By interrupting this signaling pathway, researchers were able to preserve bone health in aging mice. This discovery may have implications for developing strategies to combat age-related bone loss in humans.

Biotech2d ago

Kailera Completes Enrollment for Obesity Trials, Results Expected in 2028

Kailera has completed enrollment for its three Phase 3 trials of ribupatide, a weekly injection aimed at treating obesity. Approximately 4,900 participants will be involved in the trials, which will compare ribupatide against semaglutide. Results from these trials are anticipated to be released in mid-2028.

Biotech2d ago

Longeveron’s Stem Cell Therapy Shows Promise for Reducing Brain Inflammation in Alzheimer’s Patients

Longeveron has released new preclinical data suggesting that its stem cell therapy may lead to reduced brain inflammation in individuals with Alzheimer's disease. This finding comes from a reevaluation of data from the company's CLEAR MIND trial, which involved 49 participants. As Longeveron prepares for an investor tour, the implications of these findings could be significant for future Alzheimer's treatments.

Biotech2d ago

Heart Pill Reduces Inflammation Markers in Initial Study

Monte Rosa's NEK7-targeting drug has shown promise in reducing several heart-risk biomarkers in a trial involving 108 individuals with obesity. The drug works by targeting the NLRP3 inflammasome, which plays a key role in the inflammatory response linked to various health conditions, including heart disease. This early trial suggests potential benefits for those at risk of cardiovascular issues.

Biotech2d ago

Digbi Health Integrates Gut Data with Menopause Insights

Digbi Health has expanded its Precision Biology platform to include hormone replacement therapy (HRT) and has released results from nearly 16,000 members regarding irritable bowel syndrome (IBS). The company aims to leverage its extensive gut health data to provide insights specifically related to menopause. This development marks a significant step in understanding the intersection of gut health and hormonal changes during menopause.

Research2d ago

Prenuvo Opens Access to 200,000 MRI Scans for Research

Prenuvo, a company specializing in whole-body scans, has announced the launch of a research network that will provide access to over 200,000 MRI scans from more than 78,000 individuals. Preliminary findings indicate that 7% of participants exhibited clinically significant brain abnormalities, raising important questions about preventive health measures and the implications of early detection.

Biotech2d ago

Big Pharma Shifts Focus from Development to Acquisition

Recent findings indicate that major pharmaceutical companies are increasingly opting to acquire existing innovations rather than develop new drugs in-house. This trend is driven by challenges such as patent cliffs and declining research and development productivity. The Longevity Biotech Report reveals that the largest drugmakers control 62% of all registered biotech companies, highlighting their strategy of buying into existing scientific advancements.

Research2d ago

Immune Aging Linked to Osteoporosis and Osteoarthritis

Recent research highlights immune aging as a significant underlying factor contributing to osteoporosis and osteoarthritis. The aging immune system exacerbates degenerative conditions in bone and joint tissues, complicating the traditional understanding of these ailments. This interconnectedness suggests that addressing immune aging may be crucial for improving bone and joint health in the elderly.

Biotech2d ago

Tenvie Therapeutics Initiates Phase 1 Study of Brain-Penetrating Drug TNV313

On October 13, 2026, Tenvie Therapeutics announced the dosing of the first subject in a Phase 1 clinical trial for TNV313, a new brain-penetrating drug. This randomized ascending dose study aims to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of the drug in healthy volunteers, while also validating its distribution in the central nervous system (CNS). The trial will assess both single and multiple oral doses and explore pharmacodynamic biomarkers.

Biotech2d ago

Digbi Health Expands Precision Biology Care Nationwide

Digbi Health has launched its precision biology telehealth platform across all 50 states, partnering with OpenLoop Health and MD Integrations. This expansion allows members from over 300 employers and health plans to access a network of more than 700 healthcare professionals, including physicians and nurse practitioners. The services include GLP-1 medications and hormone replacement therapy, aimed at enhancing personalized health care.

Biotech2d ago

Inmune Bio Partners with Quantum Computing Inc. for Alzheimer's Research

Inmune Bio has announced a collaboration with Quantum Computing Inc. to leverage quantum computing and artificial intelligence in Alzheimer's research. The partnership aims to utilize Inmune Bio's extensive clinical datasets alongside QCi's quantum optimization technology to identify new applications for their drug candidate, XPro, and explore potential biomarkers associated with Alzheimer's disease. This innovative approach could enhance the understanding and treatment of neurodegenerative diseases.

Research3d ago

The Role of Gut Microbiome and Exercise in Muscle Aging and Frailty

Recent studies indicate that the gut microbiome significantly influences long-term health and the aging process, particularly in relation to muscle health and frailty. As we age, harmful microbial populations can increase while beneficial ones decline, leading to chronic inflammation and decreased tissue function. Interventions like fecal microbiota transplantation from young donors have shown promise in rejuvenating gut health and improving longevity in aged animals.

Research3d ago

Understanding SIRT1 and NAD+ Therapies in Aging

Recent research has highlighted the role of SIRT1 functional reserve in aging, indicating that its depletion may lead to age-related disorders at the cellular level. This understanding could pave the way for more effective SIRT1 and NAD+ therapies aimed at promoting longevity and health optimization. The findings emphasize the importance of maintaining SIRT1 levels to potentially mitigate the effects of aging.

Biotech3d ago

Cellino Team Launches Immune Cell Banking Service

The Cellino team has introduced a new service that allows individuals to bank their immune cells for potential future therapies. This initiative aims to preserve the youngest immune cells currently circulating in the bloodstream, potentially offering valuable resources for health optimization and longevity in the future.

Biotech3d ago

XPRIZE Awards $1 Million to Mitochondrial Drug Research Team

Mighty Therapeutics, in collaboration with the University of Washington, has received a $1 million grant from the XPRIZE Healthspan competition to advance research on elamipretide, a mitochondrial drug. The funding will support the design of a larger clinical trial aimed at older adults, utilizing pilot data to inform the study's framework. This initiative is part of a broader effort to enhance healthspan and longevity through innovative therapies.

Research3d ago

Study Reveals Blood Protein Variability in Alzheimer’s Drug Response

A recent study published in The Lancet Neurology examined 130 blood proteins in patients treated with lecanemab, an anti-amyloid drug for early Alzheimer’s disease. The findings indicate that the effectiveness of the drug varies among individuals, highlighting differences in amyloid clearance and cognitive response. This research could help tailor treatments for Alzheimer’s patients and improve outcomes.

Topics

🔬Research🥗Nutrition🏃Fitness🧬Biotech⚙️Biohacking🧠Mindset

Newsletter

Your weekly longevity signal. No spam.

Weekly Roundup

The Longevity Signal Weekly

The longevity developments that matter, every week.